Neuroloxía
Servicio
Hospital Xàtiva Lluis Alcanyis
Játiva, EspañaPublicacións en colaboración con investigadores/as de Hospital Xàtiva Lluis Alcanyis (8)
2021
-
Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente
Revista de neurologia, Vol. 72, Núm. 8, pp. 263-268
2018
-
Retrospective study of perampanel efficacy and tolerability in myoclonic seizures
Acta Neurologica Scandinavica, Vol. 138, Núm. 2, pp. 122-129
2017
-
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure
Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264
-
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
Seizure, Vol. 48, pp. 53-56
-
Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)
Epilepsy Research
2016
-
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
Epilepsy Research, Vol. 126, pp. 201-210
2015
-
Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study
Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131
2014
-
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study
Epilepsy Research, Vol. 108, Núm. 7, pp. 1243-1252